Clinical Consequences and Cost of Limiting Use of Vancomycin for Perioperative Prophylaxis: Example of Coronary Artery Bypass Surgery
Routine us of vancomycin for perioperative prophylaxis is discouraged, principally to minimize microbial resistance to it. However, outcomes and costs of this recommendation have not been assessed. We used decision-analytic models to compare clinical results and cost-effectiveness of no prophylaxis,...
Main Authors: | Giorgio Zanetti, Sue J. Goldie, Richard Platt |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2001-10-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/7/5/01-0508_article |
Similar Items
-
Local Vancomycin Usage for Prophylaxis of Surgical Site Infections
by: Emre KARA, et al.
Published: (2020-03-01) -
Infectious Prophylaxis with Intrawound Vancomycin Powder in Orthopedic Surgeries: Systematic Review with Meta-Analysis
by: David Sadigursky, et al. -
Prospective randomized study of efficacy of 1-day versus 3-day antibiotic prophylaxis for preventing surgical site infection after coronary artery bypass graft
by: Mei-Hsin Lin, et al.
Published: (2011-10-01) -
Optimal timing of antimicrobial prophylaxis before surgery
by: Saarat Sathoo, et al.
Published: (2021-12-01) -
Impact of Antibiotic Prophylaxis on Surgical Site Infections in Cardiac Surgery
by: Christian de Tymowski, et al.
Published: (2023-01-01)